CVS Appoints Former Aetna Executive as CFO
May 18 2021 - 8:29AM
Dow Jones News
By Mark Maurer
CVS Health Corp. named the former finance chief of Aetna Inc. to
lead its finances as the pharmacy chain works to administer
millions of doses of Covid-19 vaccines.
The Woonsocket, R.I.-based company on Tuesday said Shawn Guertin
would become its executive vice president and chief financial
officer, effective May 28.
Mr. Guertin is set to succeed current CFO Eva Boratto, who is
leaving the company after 11 years. Ms. Boratto has been CFO since
2018, when CVS completed its nearly $70 billion acquisition of
health insurer Aetna.
Mr. Guertin in 2018 was expected to become CVS's CFO after the
deal closed, but he decided to leave for personal and family
reasons, the company said at the time. He remained with the company
nearly a year after the transaction closed to help with the
integration.
Mr. Guertin currently serves on the boards of payroll-services
firm TriNet Group Inc. and healthcare company DaVita Inc. He worked
at Aetna from 2011 to 2019, six years of which he was CFO.
CVS earlier this month posted revenue of $69.1 billion for the
quarter ended March 31, up 3.5% from the prior-year period.
Same-store sales, or those at retail pharmacy stores that had been
operating for more than one year, climbed 0.4%. Net income was
$2.22 billion for the first quarter at CVS, up from $2 billion in
the same period last year.
CVS said earlier this month that it has given out more than 17
million Covid-19 shots at more than 8,300 U.S. locations. Like its
competitors, CVS has begun offering walk-in and same-day
appointments for injections in an effort to improve uptake.
A CVS spokesman said Mr. Guertin and Ms. Boratto weren't
available for comment.
--Anna Wilde Mathews contributed to this article.
Write to Mark Maurer at mark.maurer@wsj.com
(END) Dow Jones Newswires
May 18, 2021 08:14 ET (12:14 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
CVS Health (NYSE:CVS)
Historical Stock Chart
From Mar 2024 to Apr 2024
CVS Health (NYSE:CVS)
Historical Stock Chart
From Apr 2023 to Apr 2024